METTL5 and cancer: Emerging evidence also indicates that aberrant METTL5 expression or activity may contribute to tumorigenesis by influencing cancer cell proliferation, metabolic rewiring, and therapeutic sensitivity, highlighting its potential as both a biological regulator and a disease-associated factor (Tooley et al., 2023).